About us
True Diagnostics (True) designs and develops innovative POC diagnostic tests and devices based on its proprietary TrueDX™ Platform, which utilizes reliable and low-cost lab methods and its own proprietary or partnered biomarkers to offer rapid diagnoses to facilitate treatment decisions in point-of-care, point-of-incidence and remote-of-care settings. The TrueDX Platform’s portability and affordability allow it to be easily adopted into emerging markets to provide accurate diagnosis within minutes. For the $21 billion point-of-care market, the power of the TrueDX Platform lies in its simplicity and flexibility. Tests have an 18-month or longer shelf life with no refrigeration required. The platform’s flexible design additionally permits it to quickly commercialize a myriad of biomarkers discovered for cancer, autism, Alzheimer’s, diabetes, drugs of abuse, infectious diseases, cardiac health, traumatic brain injury, viral and bacterial infections and more.
- Website
-
http://www.truediag.com
External link for True Diagnostics™
- Industry
- Biotechnology
- Company size
- 2-10 employees
- Headquarters
- Carlsbad
- Type
- Privately Held
- Founded
- 2011
- Specialties
- in vitro diagnostics, point of care, assay development, and personalized medicine
Locations
-
Primary
2782 Loker Ave West
Carlsbad, US